SARS-CoV-2 (COVID-19) and the Endocrine System-Reference-Cited by-同舟云学术

SARS-CoV-2 (COVID-19) and the Endocrine System

Published:2020-10-01 Issue:11 Volume:4 Page:
ISSN:2472-1972
Container-title:Journal of the Endocrine Society
language:en
Short-container-title:

Author:

Lundholm Michelle D¹^ORCID,Poku Caroline²^ORCID,Emanuele Nicholas²³,Emanuele Mary Ann²,Lopez Norma²

Affiliation:

1. Department of Internal Medicine, Loyola University Medical Center, Maywood, Illinois

2. Department of Medicine, Division of Endocrinology, Loyola University Health Care System, Maywood, Illinois

3. Endocrinology Section, Medical Service, VA Hospital, Hines, Illinois

Abstract

Abstract As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system. This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function. Findings in this area are evolving, and long-term effects of infection remain an active area of further research.

Publisher

The Endocrine Society

Subject

Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jes/article-pdf/4/11/bvaa144/36841021/bvaa144.pdf

Reference125 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition;Saeedi;Diabetes Res Clin Pract.,2019

2. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes;Garbati;PLoS One.,2016

3. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area;Booth;JAMA.,2003

4. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis;Badawi;Int J Infect Dis.,2016

5. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations;Singh;Diabetes Metab Syndr.,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between COVID-19 infection and diabetes;Frontiers in Endocrinology;2024-01-10

2. Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19?;Best Practice & Research Clinical Endocrinology & Metabolism;2023-12

3. Evaluation of the hypothalamo-pituitary-adrenal axis during the post-COVID-19 period in patients treated with steroids during the illness;Archives of Endocrinology and Metabolism;2023-11-13

4. Classic endocrine disorders: implications for cardiovascular disease;Cardiovascular Endocrinology and Metabolism;2023

5. COVID-19;Pathogenic Coronaviruses of Humans and Animals;2023